TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue27,11928,01425,156
Cost of Revenue13,11412,31812,557
Gross Profit14,00515,69612,599
Operating Expenses
Research Development4,6915,1526,951
Selling General and Administrative21,10225,45434,284
Non Recurring--1,372
Total Operating Expenses--44,108
Operating Income or Loss-11,788-15,976-31,509
Income from Continuing Operations
Total Other Income/Expenses Net-4459303
Earnings Before Interest and Taxes-11,832-15,917-31,206
Interest Expense4,2694,0032,023
Income Before Tax-16,101-19,920-33,229
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-16,101-19,920-33,229
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-16,101-19,920-33,229
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-16,101-19,920-33,229